Potential regulatory role of in vitro-expanded Vδ1 T cells from human peripheral blood

Immunologic Research

Volumn 56, Issue 1, 2013, Pages 172-180

  Hua, Fang ^a   Kang, Ning ^a   Gao, Yun An ^a   Cui, Lian Xian ^a   Ba, De Nian ^a   He, Wei ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

T cells; TGF ; Tregs; V 1 T cells

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; MONOCLONAL ANTIBODY; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL EXPANSION; CONTROLLED STUDY; CYTOKINE PRODUCTION; GAMMA DELTA T LYMPHOCYTE; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; NONHUMAN; PERIPHERAL LYMPHOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; REGULATORY T LYMPHOCYTE; V DELTA 1 T LYMPHOCYTE;

ADULT; ANTIBODIES, MONOCLONAL; BLOOD CELLS; BLOOD CIRCULATION; CELL PROLIFERATION; CELLS, CULTURED; CTLA-4 ANTIGEN; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOSUPPRESSION; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA1; YOUNG ADULT;

EID: 84876420265     PISSN: 0257277X     EISSN: 15590755     Source Type: Journal    
DOI: 10.1007/s12026-013-8390-2     Document Type: Article

References (49)

1. +) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J Exp Med. 2001;193(11):1295-302.
2. +) cells: a naturally occurring population of Tregs. Blood. 2001;98(9):2736-44.
3. +CD25high regulatory cells in human peripheral blood. J Immunol. 2001;167(3):1245-53.
4. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299(5609):1057-61.
5. + Tregs. Nat Immunol. 2003;4(4):330-6.
6. Chowers Y, Holtmeier W, Harwood J, Morzycka-Wroblewska E, Kagnoff MF. The V delta 1 T cell receptor repertoire in human small intestine and colon. J Exp Med. 1994;180(1):183-90.
7. Poggi A, Venturino C, Catellani S, Clavio M, Miglino M, Gobbi M, Steinle A, Ghia P, Stella S, Caligaris-Cappio F, Zocchi MR. Vdelta1 T lymphocytes from B-CLL patients recognize ULBP3 expressed on leukemic B cells and up-regulated by trans-retinoic acid. Cancer Res. 2004;64(24):9172-9.
8. Lunardi C, Marguerie C, Walport MJ, So AK. T gamma delta cells and their subsets in blood and synovial fluid from patients with rheumatoid arthritis. Br J Rheumatol. 1992;31(8):527-30.
9. Meliconi R, Pitzalis C, Kingsley GH, Panayi GS. Gamma/delta T cells and their subpopulations in blood and synovial fluid from rheumatoid arthritis and spondyloarthritis. Clin Immunol Immunopathol. 1991;59(1):165-72.
10. Lunardi C, Marguerie C, Bowness P, Walport MJ, So AK. Reduction in T gamma delta cell numbers and alteration in subset distribution in systemic lupus erythematosus. Clin Exp Immunol. 1991;86(2):203-6.
11. Wucherpfennig KW, Newcombe J, Li H, Keddy C, Cuzner ML, Hafler DA. Gamma delta T-cell receptor repertoire in acute multiple sclerosis lesions. Proc Natl Acad Sci USA. 1992;89(10):4588-92.
12. Shimonkevitz R, Colburn C, Burnham JA, Murray RS, Kotzin BL. Clonal expansions of activated gamma/delta T cells in recent-onset multiple sclerosis. Proc Natl Acad Sci USA. 1993;90(3):923-7.
13. Wen L, Peakman M, Mieli-Vergani G, Vergani D. Elevation of activated gamma delta T cell receptor bearing T lymphocytes in patients with autoimmune chronic liver disease. Clin Exp Immunol. 1992;89(1):78-82.
14. Peng G, Wang HY, Peng W, Kiniwa Y, Seo KH, Wang RF. Tumor-infiltrating gammadelta T cells suppress T and dendritic cell function via mechanisms controlled by a unique toll-like receptor signaling pathway. Immunity. 2007;27(2):334-48.
15. + regulatory T cell mediated suppression of auto-antigen specific and polyclonal T cell responses. J Immunol Methods. 2007;322(1-2):1-11.
16. + T cells. Eur J Immunol. 2007;37(1):129-38.
17. Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, Rudensky AY. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity. 2005;22(3):329-41.
18. +CD25-T cells. J Clin Invest. 2003;112(9):1437-43.
19. +CD25-cells. Proc Natl Acad Sci USA. 2005;102(11):4103-8.
20. + Tregs. Int Immunol. 2004;16(11):1643-56.
21. +) Tregs at the single-cell level. Eur J Immunol. 2005;35(6):1681-91.
22. +CD25- T cells. J Immunol. 2007;178(7):4051-61.
23. Flores-Borja F, Jury EC, Mauri C, Ehrenstein MR. Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis. Proc Natl Acad Sci USA. 2008;105(49):19396-401.
24. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. 1995;155(3):1151-64.
25. + suppressor T cells: more questions than answers. Nat Rev Immunol. 2002;2(6):389-400.
26. + Tregs. J Exp Med. 2005;201(7):1061-7.
27. Selvaraj RK, Geiger TL. A kinetic and dynamic analysis of Foxp3 induced in T cells by TGF-beta. J Immunol. 2007;178(12):7667-77.
28. + Tregs by TGF-beta induction of transcription factor Foxp3. Eur J Immunol. 2011;41(5):1420-34.
29. +) gammadelta T cells in mouse and human. Immunol Lett. 2009;125(2):105-13.
30. Li X, Kang N, Zhang X, Dong X, Wei W, Cui L, Ba D, He W. Generation of human regulatory gammadelta T cells by TCRgammadelta stimulation in the presence of TGF-beta and their involvement in the pathogenesis of systemic lupus erythematosus. J Immunol. 2011;186(12):6693-700.
31. + tregs. Int J Clin Exp Med. 2008;1(3):192-202.
32. Annes JP, Chen Y, Munger JS, Rifkin DB. Integrin alphaVbeta6-mediated activation of latent TGF-beta requires the latent TGF-beta binding protein-1. J Cell Biol. 2004;165(5):723-34.
33. Li MO, Sanjabi S, Flavell RA. Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity. 2006;25(3):455-71.
34. Letterio JJ, Roberts AB. Regulation of immune responses by TGF-beta. Annu Rev Immunol. 1998;16:137-61.
35. + natural Tregs in dominant self-tolerance and autoimmune disease. Immunol Rev. 2006;212:8-27.
36. Muller YD, Seebach JD, Buhler LH, Pascual M, Golshayan D. Transplantation tolerance: clinical potential of Tregs. Self Nonself. 2011;2(1):26-34.
37. + T cells in vivo. J Immunol. 2009;182(12):7490-500.
38. Jain N, Nguyen H, Chambers C, Kang J. Dual function of CTLA-4 in Tregs and conventional T cells to prevent multiorgan autoimmunity. Proc Natl Acad Sci USA. 2010;107(4):1524-8.
39. Salomon B, Bluestone JA. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu Rev Immunol. 2001;19:225-52.
40. Tivol EA, Borriello F, Schweitzer AN, Lynch WP, Bluestone JA, Sharpe AH. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity. 1995;3(5):541-7.
41. Waterhouse P, Penninger JM, Timms E, Wakeham A, Shahinian A, Lee KP, Thompson CB, Griesser H, Mak TW. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science. 1995;270(5238):985-8.
42. Pestka S, Krause CD, Sarkar D, Walter MR, Shi Y, Fisher PB. Interleukin-10 and related cytokines and receptors. Annu Rev Immunol. 2004;22:929-79.
43. Schmetterer KG, Neunkirchner A, Pickl WF. Naturally occurring Tregs: markers, mechanisms, and manipulation. FASEB J. 2012;26(6):2253-76.
44. + immunoTregs suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med. 1998;188(2):287-96.
45. + immunoregulatory cells. J Immunol. 2001;167(3):1137-40.
46. + T cells expressing the natural cytotoxicity receptor NKp30 for recognition of lymphoid leukemia cells. Blood. 2011;118(4):992-1001.
47. Siegers GM, Dhamko H, Wang XH, Mathieson AM, Kosaka Y, Felizardo TC, Medin JA, Tohda S, Schueler J, Fisch P, Keating A. Human Vdelta1 gammadelta T cells expanded from peripheral blood exhibit specific cytotoxicity against B-cell chronic lymphocytic leukemia-derived cells. Cytotherapy. 2011;13(6):753-64.
48. Casetti R, Martino A. The plasticity of gamma delta T cells: innate immunity, antigen presentation and new immunotherapy. Cell Mol Immunol. 2008;5(3):161-70.
49. Carding SR, Egan PJ. Gammadelta T cells: functional plasticity and heterogeneity. Nat Rev Immunol. 2002;2(5):336-45.